(Q40927884)

24 September 2017

1 reference

title

Metformin and free fatty acid metabolism (English)

1 reference

24 September 2017

0 references

1 reference

Del Prato S

1

1 reference

24 September 2017

Marchetto S

2

1 reference

24 September 2017

Pipitone A

3

1 reference

24 September 2017

Zanon M

4

1 reference

24 September 2017

Vigili de Kreutzenberg S

5

1 reference

24 September 2017

Tiengo A

6

1 reference

24 September 2017

language of work or name

1 reference

1 September 1995

1 reference

Diabetes/metabolism reviews

24 September 2017

published in

1 reference

24 September 2017

volume

11 Suppl 1

1 reference

24 September 2017

page(s)

S33-41

1 reference

Effect of metformin on glucose metabolism in the splanchnic bed

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110506

The biguanide inhibition of d-glucose transport in membrane vesicles from small intestinal brush borders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110506

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110506

7 January 2021

Comparative effects of phenformin, metformin and glibenclamide on metabolic rhythms in maturity-onset diabetics

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110506

7 January 2021

Insulin Receptor Binding to Monocytes, Insulin Secretion, and Glucose Tolerance Following Metformin Treatment: Results of a Double-Blind Cross-Over Study in Type II Diabetics

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110506

7 January 2021

Metformin normalizes insulin binding to monocytes from obese nondiabetic subjects and obese type II diabetic patients

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110506

7 January 2021

Effect of metformin on insulin receptor binding and glycaemic control in type II diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110506

7 January 2021

Mechanism of Action of Metformin: Insulin Receptor and Postreceptor Effects in Vitro and in Vivo*

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110506

7 January 2021

The effect of metformin on glycaemic control, intermediary metabolism and blood pressure in non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110506

7 January 2021

Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110506

7 January 2021

The effects of metformin on adipocyte insulin action and metabolic control in obese subjects with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110506

7 January 2021

Improvement with metformin in insulin internalization and processing in monocytes from NIDDM patients.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110506

7 January 2021

Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110506

7 January 2021

Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110506

7 January 2021

Double-blind evaluation of efficacy and tolerability of metformin in NIDDM.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110506

7 January 2021

Mechanism of metformin action in non-insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110506

7 January 2021

Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110506

7 January 2021

Direct effects of biguanides on glucose utilization in vitro

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110506

7 January 2021

Comparison of the in vitro effect of biguanides and sulfonylureas on insulin binding of its receptors in target cells

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110506

7 January 2021

Pathogenesis of NIDDM. A balanced overview

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110506

7 January 2021

Effect of metformin treatment on insulin action in diabetic rats: in vivo and in vitro correlations.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110506

7 January 2021

Cellular mechanism of action of metformin

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110506

7 January 2021

On the determination of basal glucose production rate in patients with type 2 (non-insulin-dependent) diabetes mellitus using primed-continuous 3-3H-glucose infusion.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110506

7 January 2021

Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110506

7 January 2021

Specific Inhibition of Gluconeogenesis by Biguanides

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110506

7 January 2021

The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110506

7 January 2021

Mechanism of action of antilipolytic agents: comparison of the effects of insulin, tolbutamide, and phenformin on lipolysis induced by dibutyryl cyclic AMP plus theophylline

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110506

7 January 2021

In vitro effects of phenformin hydrochloride: observations using isolated fat cells

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110506

7 January 2021

[Increase in 14CO2 formation from 14C-glucose in rats caused by the oral antidiabetic butylbiguanide hydrochloride]

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110506

7 January 2021

Effects of biguanides on fatty acid and glucose oxidation in muscle.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110506

7 January 2021

Metformin administration in hyperlipidemic states

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110506

7 January 2021

Effect of phenformin on lipid transport in hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110506

7 January 2021

[Demonstration of the mechanism of action of biguanides (author's transl)]

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110506

7 January 2021

Role of insulin resistance in adipose tissue and liver in the pathogenesis of endogenous hypertriglyceridaemia in man

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110506

7 January 2021

Increased Rate of Cori Cycle in Obese Subjects With NIDDM and Effect of Weight Reduction

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110506

7 January 2021

Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110506

7 January 2021

Ambient plasma free fatty acid concentrations in noninsulin-dependent diabetes mellitus: evidence for insulin resistance.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110506

7 January 2021

Insulin regulation of glucose and lipid metabolism in massive obesity

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110506

7 January 2021

Mechanism for the stimulation of gluconeogenesis by fatty acids in perfused rat liver

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110506

7 January 2021

Stimulation of gluconeogenesis by palmitic acid in rat hepatocytes: evidence that this effect can be dissociated from the provision of reducing equivalents.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110506

7 January 2021

Identifiers

DOI

10.1002/DMR.5610110506

1 reference

24 September 2017

1 reference